Company News
CNS Pharmaceuticals Raises $22.5M, Stock Jumps 258%
CNS Pharmaceuticals announced a private placement of 650,000 shares at $2.30 and pre‑funded warrants, targeting $22.5 million gross proceeds.
The financing, backed by ADAR1 Capital, Ikarian Capital, S
